Veradigm PE Ratio 2010-2022 | MDRX
Current and historical p/e ratio for Veradigm (MDRX) from 2010 to 2022. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Veradigm PE ratio as of August 15, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Veradigm PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2025-08-15 | 4.60 | 0.00 | |
2022-12-31 | 17.64 | $-0.25 | 0.00 |
2022-09-30 | 15.23 | $0.43 | 35.42 |
2022-06-30 | 14.83 | $0.43 | 34.49 |
2022-03-31 | 22.52 | $1.12 | 20.11 |
2021-12-31 | 18.45 | $1.01 | 18.27 |
2021-09-30 | 13.37 | $5.15 | 2.60 |
2021-06-30 | 18.51 | $5.03 | 3.68 |
2021-03-31 | 15.02 | $4.83 | 3.11 |
2020-12-31 | 14.44 | $4.64 | 3.11 |
2020-09-30 | 8.14 | $-0.30 | 0.00 |
2020-06-30 | 6.77 | $-0.33 | 0.00 |
2020-03-31 | 7.04 | $-1.18 | 0.00 |
2019-12-31 | 9.82 | $-1.09 | 0.00 |
2019-09-30 | 10.98 | $1.17 | 9.38 |
2019-06-30 | 11.63 | $1.00 | 11.63 |
2019-03-31 | 9.54 | $2.26 | 4.22 |
2018-12-31 | 9.64 | $2.08 | 4.63 |
2018-09-30 | 14.25 | $-0.03 | 0.00 |
2018-06-30 | 12.00 | $0.01 | 1200.00 |
2018-03-31 | 12.35 | $-1.20 | 0.00 |
2017-12-31 | 14.55 | $-1.09 | 0.00 |
2017-09-30 | 14.23 | $-1.16 | 0.00 |
2017-06-30 | 12.76 | $-1.06 | 0.00 |
2017-03-31 | 12.68 | $-0.26 | 0.00 |
2016-12-31 | 10.21 | $-0.14 | 0.00 |
2016-09-30 | 13.17 | $-0.01 | 0.00 |
2016-06-30 | 12.70 | $0.02 | 635.00 |
2016-03-31 | 13.21 | $0.06 | 220.17 |
2015-12-31 | 15.38 | $-0.01 | 0.00 |
2015-09-30 | 12.40 | $-0.11 | 0.00 |
2015-06-30 | 13.68 | $-0.23 | 0.00 |
2015-03-31 | 11.96 | $-0.31 | 0.00 |
2014-12-31 | 12.77 | $-0.37 | 0.00 |
2014-09-30 | 13.42 | $-0.48 | 0.00 |
2014-06-30 | 16.05 | $-0.60 | 0.00 |
2014-03-31 | 18.03 | $-0.64 | 0.00 |
2013-12-31 | 15.46 | $-0.59 | 0.00 |
2013-09-30 | 14.87 | $-0.61 | 0.00 |
2013-06-30 | 12.94 | $-0.29 | 0.00 |
2013-03-31 | 13.59 | $-0.12 | 0.00 |
2012-12-31 | 9.42 | $-0.02 | 0.00 |
2012-09-30 | 12.42 | $0.26 | 47.77 |
2012-06-30 | 10.93 | $0.32 | 34.16 |
2012-03-31 | 16.60 | $0.36 | 46.11 |
2011-12-31 | 18.94 | $0.39 | 48.56 |
2011-09-30 | 18.02 | $0.22 | 81.91 |
2011-06-30 | 19.42 | $0.12 | 161.83 |
2011-03-31 | 20.99 | $0.14 | 149.93 |
2010-12-31 | 19.27 | $0.08 | 240.88 |
2010-09-30 | 18.47 | $0.23 | 80.30 |
2010-06-30 | 16.10 | $0.22 | 73.18 |
2010-05-31 | 18.81 | $0.12 | 156.75 |
2010-03-31 | 19.58 | $0.12 | 163.17 |
2010-02-28 | 17.89 | $0.09 | 198.78 |
2009-12-31 | 20.23 | $0.09 | 224.78 |
2009-11-30 | 19.20 | $0.09 | 213.33 |
2009-09-30 | 20.27 | $0.09 | 225.22 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.498B | $0.588B |
Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Veeva Systems (VEEV) | United States | $45.855B | 58.34 |
Tempus AI (TEM) | United States | $12.773B | 0.00 |
Doximity (DOCS) | United States | $12.199B | 54.27 |
Hims & Hers Health (HIMS) | United States | $10.301B | 85.22 |
IRhythm Technologies (IRTC) | United States | $5.159B | 0.00 |
Hinge Health (HNGE) | United States | $4.608B | 0.00 |
Privia Health (PRVA) | United States | $2.610B | 193.36 |
Inspire Medical Systems (INSP) | United States | $2.596B | 38.16 |
Phreesia (PHR) | United States | $1.708B | 0.00 |
Enovis (ENOV) | United States | $1.689B | 8.93 |
10x Genomics (TXG) | United States | $1.645B | 0.00 |
Omnicell (OMCL) | United States | $1.456B | 28.04 |
Schrodinger (SDGR) | United States | $1.422B | 0.00 |
Azenta (AZTA) | United States | $1.393B | 60.78 |
Clover Health Investments (CLOV) | United States | $1.358B | 0.00 |
Claritev (CTEV) | United States | $1.180B | 0.00 |
Evolent Health (EVH) | United States | $1.092B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.651B | 0.00 |
Zepp Health (ZEPP) | Netherlands | $0.491B | 0.00 |
Standard BioTools (LAB) | United States | $0.467B | 0.00 |
Talkspace (TALK) | United States | $0.429B | 128.00 |
Carlsmed (CARL) | $0.360B | 0.00 | |
Butterfly Network (BFLY) | United States | $0.360B | 0.00 |
TruBridge (TBRG) | United States | $0.289B | 50.74 |
Outset Medical (OM) | United States | $0.236B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.235B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.212B | 0.00 |
Health Catalyst (HCAT) | United States | $0.205B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.193B | 0.00 |
CapsoVision (CV) | United States | $0.178B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.135B | 0.00 |
American Well (AMWL) | United States | $0.115B | 0.00 |
CareCloud (CCLD) | United States | $0.110B | 5.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.094B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.092B | 0.00 |
Insight Molecular Diagnostics (IMDX) | United States | $0.069B | 0.00 |
Pulmonx (LUNG) | United States | $0.064B | 0.00 |
111 (YI) | China | $0.058B | 0.00 |
P3 Health Partners (PIII) | United States | $0.049B | 0.00 |
HeartBeam (BEAT) | United States | $0.035B | 0.00 |
Precipio (PRPO) | United States | $0.024B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.023B | 0.00 |
Zhongchao (ZCMD) | China | $0.023B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
HeartSciences (HSCS) | United States | $0.008B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
MSP Recovery (MSPR) | United States | $0.005B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
Movano (MOVE) | United States | $0.004B | 0.00 |
Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
PROFUSA (PFSA) | United States | $0.003B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |